Cargando…

Gastrointestinal symptoms in patients with coronavirus disease 2019 (COVID-19) – friend or foe?

INTRODUCTION: Gastrointestinal (GI) symptoms can be considered as a manifestation of coronavirus disease 2019 (COVID-19). AIM: Our study analysed GI symptoms depending on their occurrence, and their possible causes and impact on the course of COVID-19. MATERIAL AND METHODS: A retrospective, single-c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lewandowski, Konrad, Kaniewska, Magdalena, Rosołowski, Mariusz, Tworek, Adam, Rydzewska, Grażyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475485/ https://www.ncbi.nlm.nih.gov/pubmed/36127941 http://dx.doi.org/10.5114/pg.2021.111000

Ejemplares similares

Gastrointestinal symptoms in COVID-19
por: Lewandowski, Konrad, et al.
Publicado: (2022)

The effectiveness of microencapsulated sodium butyrate at reducing symptoms in patients with irritable bowel syndrome
por: Lewandowski, Konrad, et al.
Publicado: (2022)

Skin and gastrointestinal symptoms in COVID-19
por: Ciechanowicz, Piotr, et al.
Publicado: (2020)

Long-lasting dyspeptic symptoms – another consequence of the COVID-19 pandemic?
por: Nazarewska, Anna, et al.
Publicado: (2023)

The Use of Virtual Reality to Reduce Stress among Inflammatory Bowel Disease Patients Treated with Vedolizumab
por: Lewandowski, Konrad, et al.
Publicado: (2021)

Biosimilar infliximab versus originator in Crohn’s disease anti-TNF-α naïve and non-naïve patients
por: Kaniewska, Magdalena, et al.
Publicado: (2020)

Low-FODMAP Diet for the Management of Irritable Bowel Syndrome in Remission of IBD
por: Więcek, Martyna, et al.
Publicado: (2022)

Selected Aspects of Nutrition in the Prevention and Treatment of Inflammatory Bowel Disease
por: Panufnik, Paulina, et al.
Publicado: (2022)

The efficacy and safety of the biosimilar product (Inflectra(®)) compared to the reference drug (Remicade(®)) in rescue therapy in adult patients with ulcerative colitis
por: Kaniewska, Magdalena, et al.
Publicado: (2017)

Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients
por: Szczubełek, Martyna, et al.
Publicado: (2021)

Reply to van Lingen et al. Comment on “Szczubełek et al. Effectiveness of Crohn’s Disease Exclusion Diet for Induction of Remission in Crohn’s Disease Adult Patients. Nutrients 2021, 13, 4112”
por: Szczubełek, Martyna, et al.
Publicado: (2022)

Microbiota of the gastrointestinal tract: Friend or foe?
por: Senchukova, Marina A
Publicado: (2023)

Effective treatment of severe acute pancreatitis and COVID-19 pneumonia with tocilizumab
por: Zielecki, Piotr, et al.
Publicado: (2020)

Antibiotics and immunotherapy in gastrointestinal tumors: Friend or foe?
por: Yan, Cong, et al.
Publicado: (2019)

ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)

Gut microbiome in gastrointestinal cancer: a friend or foe?
por: Liu, Yang, et al.
Publicado: (2022)

Interleukin-33: Friend or Foe in Gastrointestinal Tract Cancers?
por: Pisani, Laura Francesca, et al.
Publicado: (2023)

Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease—Do We Already Know Everything?
por: Lewandowski, Konrad, et al.
Publicado: (2023)

Friend and Foe
Publicado: (1890)

Elastin-Derived Peptides in the Central Nervous System: Friend or Foe
por: Szychowski, Konrad A., et al.
Publicado: (2021)

Chemokines and Cancer: Friends or Foes?
por: Strazza, Marianne, et al.
Publicado: (2020)

Preparation for endoscopic examinations in patients with diabetes and hypoglycaemia
por: Lewandowski, Konrad, et al.
Publicado: (2021)

Inflammation: friend or foe of bovine reproduction?
por: Chastant, Sylvie, et al.
Publicado: (2019)

Estetrol and Mammary Gland: Friends or Foes?
por: Gallez, Anne, et al.
Publicado: (2021)

Guest edited collection: current friends and foes in gastrointestinal cancer
por: Sica, Giuseppe S.
Publicado: (2021)

Therapeutic and prophylactic management of bleeding from oesophageal and gastric varices – recommendations of the Working Group of the National Consultant for Gastroenterology
por: Rosołowski, Mariusz, et al.
Publicado: (2014)

The COVID-19 facemask: Friend or foe?
por: Hallock, Geoffrey G.
Publicado: (2021)

Testosterone in COVID-19: Friend or Foe?
por: Niemann, Peter J., et al.
Publicado: (2021)

Estrogen and COVID-19: friend or foe?
por: Di Vincenzo, A., et al.
Publicado: (2021)

Phytoestrogens. Friends or foes?
por: Barrett, J
Publicado: (1996)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Antioxidants - friend or foe?
por: Meffert, Hans
Publicado: (2008)

Inflammation: Friend and Foe
por: Kjekshus, John
Publicado: (2015)

Leukocytes: friend or foe
por: Bellingan, G
Publicado: (2000)

Viruses: Friends or foes
por: Michán, Carmen, et al.
Publicado: (2021)

Sphingolipids: Friends or Foes?
por: Hayashi, Hiroshi
Publicado: (2022)

Gabapentin—Friend or foe?
por: Russo, Marc, et al.
Publicado: (2022)

Is Cryotherapy Friend or Foe for Symptomatic Cervical Ectopy?
por: Çekmez, Yasemin, et al.
Publicado: (2015)

Biosimilar biological drugs in the treatment of inflammatory bowel diseases
por: Kaniewska, Magdalena, et al.
Publicado: (2019)

Management of anaemia in patients with inflammatory bowel disease – results of a questionnaire among Polish healthcare professionals
por: Tulewicz-Marti, Edyta M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jv0ptol0hqtf4c763ttnnf9rsn